• Skip to primary navigation
  • Skip to main content
  • Skip to footer

LKT Labs

Biochemicals for Life Science Research

  • Products
    • New Products
    • Cancer Biology
    • Cardiovascular
    • Endocrine Signaling and Immunology
    • Metabolic and GI Pathology
    • Microbiology
    • Natural Products
    • Neuroscience
    • Peptides
    • Pharmaceutical Impurities and Derivatives
    • Stem Cell Modulators
  • Services
    • Custom Synthesis
    • Natural Product Isolation
    • Analytical Services
  • Int’l Distributors
  • Support
    • About LKT Labs
    • General Inquiry
    • Bulk Quote Request
    • Document Request
    • Technical Support
    • Catalog Request
    • Product Flyers
  • Contact Us
  • Cart
  • Login / Register
PTC124

PTC124

Product ID P7608
Cas No. 775304-57-9
Purity ≥98%
Product Unit SizeCostQuantityStock
5 mg $76.10 In stock
25 mg $270.00 In stock
100 mg $650.00 Please Inquire
Bulk Quote

Quicklinks

  • Description
  • Product Info
  • Shipping and Storage
  • Downloads
  • References
  • Description
  • Product Info
  • Shipping and Storage
  • Downloads
  • References
  • Custom Order

Description

PTC124 allows read-through of premature stop codons in mRNA, enabling proper protein translation. This compound is used to treat Duchenne muscular dystrophy (DMD) and cystic fibrosis as well as other nonsense mutation disorders.

Product Info

Cas No.

775304-57-9

Purity

≥98%

Formula

C15H9FN2O3

Formula Wt.

284.25

IUPAC Name

3-[5-(2-fluorophenyl)-1,2,4-oxadiazol-3-yl]benzoic acid

Synonym

PTC-124, Ataluren, Translarna™

Solubility

DMSO 57 mg/mL (200mM) Water Insoluble Ethanol Insoluble

Shipping and Storage

Store Temp

-20°C

Ship Temp

Ambient

Downloads

MSDS

P7608 MSDS PDF

Info Sheet

P7608 Info Sheet PDF

References

Bushby K, Finkel R, Wong B, et al. Ataluren treatment of patients with nonsense mutation dystrophinopathy. Muscle Nerve. 2014 Oct;50(4):477-87. PMID: 25042182.

Ryan NJ. Ataluren: first global approval. Drugs. 2014 Sep;74(14):1709-14. PMID: 25193627.

Nagel-Wolfrum K, Möller F, Penner I, et al. Translational read-through as an alternative approach for ocular gene therapy of retinal dystrophies caused by in-frame nonsense mutations. Vis Neurosci. 2014 Sep;31(4-5):309-16. PMID: 24912600.

Custom Order

  • Size of single unit expressed as number (e.g. '500' in the case of 500 mg)
  • Total quantity of unit size desired (e.g. '10' in the case of 10 x 500 mg). If only one unit is desired, you may leave this blank.
  • This field is for validation purposes and should be left unchanged.

Related Products

  • L5767

    Loratadine

    Histamine H1 antagonist, FIASMA.

    ≥98%
  • M4000

    MK-2206 Monohydrochloride

    Akt inhibitor.

    ≥99%
  • F465818

    Fluorouracil Impurity B

    Fluorouracil impurity

    ≥95%
  • C4556

    Clofibric Acid

    Metabolite of clofibrate; PPARα agonist.

    ≥98%
  • T6931

    Triclosan

    Diarylether; bacterial ENR binder, fatty acid s...

    ≥98%
  • C5680

    Coumestrol

    Phytoestrogen found in various plant sources; E...

    ≥97%
  • P200097

    PF-06821497

    EZH2 inhibitor

    ≥99%
  • A0920

    N-Acetyl-S-(N′-phenethylthiocarbamoyl)-L-cysteine

    N-acetyl cysteine conjugate of phenethylisothiocya...
    ≥95%
  • T698579

    Tropodithietic Acid

    Produced by various marine proteobacteria

    ≥99%
  • E4902

    Emamectin B1 Benzoate

    Semi-synthetic avermectin; GABA potentiator.

    ≥80%
  • T1010

    7-Acetyl Paclitaxel

    Synthesis impurity

    ≥98%
  • R3206

    Riboflavin

    Essential vitamin (B2) found in vegetables, dai...

    ≥97%
  • L1983

    Leucomyosuppressin

    Peptide found in insects.

    ≥95%
  • C5592

    CNX-774

    BTK inhibitor.

    ≥98%
  • I5354

    Iniparib

    Cysteine adduct inducer, PARP-1 inhibitor.

    ≥98%
  • G7345

    GSK-2606414

    PERK inhibitor.

    ≥99%
  • G7442

    GSK-343

    EZH2 HMT inhibitor.

    ≥98%
  • A4931

    3-Aminobenzamide

    PARP inhibitor.

    ≥97%
  • C179602

    CEP-28122

    ALK inhibitor.

    ≥98%
  • E2003

    Efavirenz

    Non-nucleoside RT inhibitor.

    ≥99%

Footer

  • Contact Us
  • About Us
  • Site Map
  • Terms and Conditions
LKT Laboratories, Inc.
545 Phalen Blvd.
St. Paul MN, 55130

Ph: (888)-558-5227
Fax: (888)-558-7329

©2025 LKT Laboratories, All Rights Reserved - Products for research use only